0 likes | 8 Views
Learn about the revolutionary effects of enasidenib at The Good and Bad of Enasidenib. As a top healthcare provider specializing in various cancer therapies, we provide hope and recovery. Discover the advantages that make Enasidenib a beacon of progress in cancer therapy. However, we also address potential obstacles, ensuring that individuals seeking innovative healthcare solutions make educated decisions. Trust us, your healthcare improvement partner, while we traverse the complexities of Enasidenib's cancer-fighting path.<br>
E N D
ENASIDENIB Home | Cancer | Blood Cancer | ENASIDENIB ENASIDENIB Tablets Description Composition Dosage Indications IDHIFA (enasidenib) is an inhibitor of isocitrate dehydrogenase-2 (IDH2) enzyme. IDHIFA (enasidenib) is available as a 50-mg tablet (equivalent to 60 mg enasidenib mesylate) and a 100-mg tablet (equivalent to 120 mg enasidenib mesylate) for oral administration. Each tablet contains inactive ingredients of colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose acetate succinate, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium lauryl sulfate, sodium starch glycolate, talc, and titanium dioxide. Copyright © 2024 ImpoMed Convert web pages and HTML files to PDF in your applications with the Pdfcrowd HTML to PDF API Printed with Pdfcrowd.com